| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition II Corp. | Director | Ordinary shares | 100,000 | $987,000 | $9.87 | 26 Sep 2025 | Direct |
| Drugs Made In America Acquisition Corp. | Director | Ordinary shares | 100,000 | 29 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | 26 Sep 2025 | 1 | $0 | 4 | Director | 02 Oct 2025, 14:51 |
| DMII | Drugs Made In America Acquisition II Corp. | 24 Sep 2025 | 0 | $0 | 3 | Director | 24 Sep 2025, 17:42 |
| DMAA | Drugs Made In America Acquisition Corp. | 29 Jan 2025 | 1 | $0 | 4 | Director | 03 Feb 2025, 19:27 |
| DMAA | Drugs Made In America Acquisition Corp. | 07 Jan 2025 | 0 | $0 | 3 | Director | 10 Jan 2025, 07:43 |